J Lin

Summary

Affiliation: Thomas Jefferson University
Country: USA

Publications

  1. doi request reprint Targeting epigenetics for the treatment of prostate cancer: recent progress and future directions
    Jianqing Lin
    Department of Medical Oncology, Jefferson Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Semin Oncol 40:393-401. 2013
  2. doi request reprint Targeting angiogenesis as a promising modality for the treatment of prostate cancer
    Jianqing Lin
    Department of Medical Oncology, Jefferson Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Urol Clin North Am 39:547-60. 2012
  3. ncbi request reprint HIF-1alpha and calcium signaling as targets for treatment of prostate cancer by cardiac glycosides
    J Lin
    Jefferson Kimmel Cancer Center, 834 Chestnut Street, Suite 314, Philadelphia, PA 19107, USA
    Curr Cancer Drug Targets 9:881-7. 2009
  4. doi request reprint Hospital-based costs associated with venous thromboembolism treatment regimens
    G Merli
    Jefferson Center for Vascular Diseases, Thomas Jefferson University, Philadelphia, PA, USA
    J Thromb Haemost 6:1077-86. 2008
  5. doi request reprint Real-world practices to prevent venous thromboembolism with pharmacological prophylaxis in US orthopedic surgery patients: an analysis of an integrated healthcare database
    G J Merli
    Jefferson Vascular Center, Thomas Jefferson University Hospitals, Philadelphia, PA 19107, USA
    J Thromb Thrombolysis 32:89-95. 2011

Detail Information

Publications5

  1. doi request reprint Targeting epigenetics for the treatment of prostate cancer: recent progress and future directions
    Jianqing Lin
    Department of Medical Oncology, Jefferson Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Semin Oncol 40:393-401. 2013
    ..Combinations of epigenetic agents alone or with a targeted agent such as androgen receptor signaling inhibitors are promising approaches and will be discussed further. ..
  2. doi request reprint Targeting angiogenesis as a promising modality for the treatment of prostate cancer
    Jianqing Lin
    Department of Medical Oncology, Jefferson Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Urol Clin North Am 39:547-60. 2012
    ..Targeting angiogenesis is still a promising treatment strategy in prostate cancer with a rational trial design and combination approach...
  3. ncbi request reprint HIF-1alpha and calcium signaling as targets for treatment of prostate cancer by cardiac glycosides
    J Lin
    Jefferson Kimmel Cancer Center, 834 Chestnut Street, Suite 314, Philadelphia, PA 19107, USA
    Curr Cancer Drug Targets 9:881-7. 2009
    ..The possible application of digoxin and other cardiac glycosides in cancer therapeutics especially in prostate cancer is discussed...
  4. doi request reprint Hospital-based costs associated with venous thromboembolism treatment regimens
    G Merli
    Jefferson Center for Vascular Diseases, Thomas Jefferson University, Philadelphia, PA, USA
    J Thromb Haemost 6:1077-86. 2008
    ..With upcoming US national performance measures requiring successful implementation of evidence-based therapy, cost considerations for anticoagulant choice are of increasing importance to hospitals...
  5. doi request reprint Real-world practices to prevent venous thromboembolism with pharmacological prophylaxis in US orthopedic surgery patients: an analysis of an integrated healthcare database
    G J Merli
    Jefferson Vascular Center, Thomas Jefferson University Hospitals, Philadelphia, PA 19107, USA
    J Thromb Thrombolysis 32:89-95. 2011
    ..Further efforts are required to ensure the recommended duration of thromboprophylaxis is prescribed to all patients and continued outpatient VTE prophylaxis is provided...